The Hungarian Centre of Excellence for Molecular Medicin consortium (HCEMM-MOLMEDEX), composed by the University of Szeged, the Biological Research Centre of the Hungarian Academy of Sciences, the University of Debrecen, Semmelweis University, and the European Molecular Biology Laboratory, has been awarded EUR 15 million by the Teaming Programme of Horizon 2020 to set up the Hungarian Centre of Excellence for Molecular Medicine with a focus on translational medicine and clinical application of basic research results. The research teams participating in the project have already made significant progress in understanding the molecular disorder causing morbid obesity, diabetes, heart failure, genomic instability and carcinogenesis, coeliac disease and macula degeneration, in identifying therapeutic targets. The project partners have jointly designed the long-term scientific, strategic and sustainability plan of MOLMEDEX.

The research programmes of the new centre of excellence will be implemented in Szeged, Budapest, and Debrecen.

The total budget of the project for 7 years is nearly EUR 52 million, financed by Hungarian funds, as well as the Economic Development and Innovation Operational Programme, co-funded by the EU Structural Funds.

Péter Horváth gave a presentation on MOLMEDEX at the first Dialogue WS of the ResInfra@DR project on 31st August in Budapest, with an emphasis on the so-called Core Facility, that is the RI element, of MOLMEDEX.

Read further details on MOLMEDEX…

Photo credit: ResInfra@DR 2017